Medical Device Network on MSN2d
City of Hope and MSK develop tool to predict CAR T therapy outcomes for NHLResearchers from the City of Hope and Memorial Sloan Kettering (MSK) Cancer Center, US, have developed a tool named ...
AstraZeneca and the Memorial Sloan Kettering Cancer Center (MSK) have tapped digital health tech company IgniteData to ...
Physician-scientists at Memorial Sloan Kettering Cancer Center (MSK) recently published two papers that advance the science ...
Memorial Sloan Kettering Cancer Center treats more than 400 types of cancer.Memorial Sloan Kettering Cancer Center treats more than 400 types of cancer. Learning that you have cancer can be an ...
Clinical Trials Arena on MSN3d
IgniteData to deploy EHR-to-EDC automation tool in Phase III trial at MSKBy the secure transfer of data from EHRs to EDCs, the platform removes the necessity for manually entering the data.
News Medical on MSN17h
Clinical trial demonstrates safety of targeted treatment approach for deadly brain tumor in childrenA Phase I clinical trial demonstrated that a targeted approach to treating a deadly brain tumor in children called diffuse intrinsic pontine glioma (DIPG) is safe, reported Weill Cornell Medicine and ...
New York City-based Memorial Sloan Kettering Cancer Center plans to implement Abridge’s AI platform across its system in 2025 and 2026. The platform transcribes medical conversations into real ...
Actinium Pharmaceuticals (ATNM) has entered into a sponsored research agreement with Memorial Sloan Kettering Cancer Center to expand ...
This is the 11th year that Little Eric’s Foundation participated, as an organization, in Cycle for Survival in New York City.
HealthDay on MSN7d
Pelabresib Plus Ruxolitinib Improves Underlying MyelofibrosisPelabresib, a bromodomain and extraterminal domain inhibitor, plus ruxolitinib (a Janus kinase [JAK] inhibitor) improves ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback